Menu

Blog

Archive for the ‘neuroscience’ category: Page 10

Mar 1, 2024

Prof Nadeem Sarwar — Corporate VP, Co-Founder & Head, Transformational Prevention Unit, Novo Nordisk

Posted by in categories: biotech/medical, business, genetics, government, health, neuroscience

Professor Nadeem Sarwar is Corporate Vice President, Co-Founder and Head, Transformational Prevention Unit, Novo Nordisk (https://www.novonordisk.com/partnerin…), Co-Chair UK Dementia Mission (a UK Government Ministerial appointment) and Honorary Professor, University of Edinburgh Medical School.

Professor Sarwar joined Novo Nordisk in June 2023 as Corporate Vice President, Co-Founder and Head of Novo Nordisk’s new Transformational Prevention Unit (TPU) whose mission is to increase obesity-free life years, so people live healthier and longer lives. To achieve this, the TPU is establishing an integrated ecosystem that will deliver science-first, empowering, and scalable commercial solutions that predict and pre-empt obesity and its consequences through innovative partnerships, with solutions intending to push the boundaries of what is possible with drugs, genomics, microbiome, digital health, and behavioral science.

Continue reading “Prof Nadeem Sarwar — Corporate VP, Co-Founder & Head, Transformational Prevention Unit, Novo Nordisk” »

Feb 29, 2024

Q&A: How a potential treatment for Alzheimer’s disease could also work for type 2 diabetes

Posted by in categories: biotech/medical, neuroscience

Of the 38 million Americans who have diabetes, at least 90% have type 2, according to the Centers for Disease Control and Prevention. Type 2 diabetes occurs over time and is characterized by a loss of the cells in the pancreas that make the hormone insulin, which helps the body manage sugar.

These cells make another protein, called islet amyloid polypeptide or IAPP, which has been found clumped together in many type 2 diabetes patients. The formation of IAPP clusters is comparable to how a protein in the brains of Alzheimer’s disease patients sticks together to eventually form the signature plaques associated with that disease.

Researchers at the University of Washington have demonstrated more similarities between IAPP clusters and those in Alzheimer’s. The team previously showed that a can block the formation of small, toxic Alzheimer’s protein clusters. Now, in a recently published paper in Protein Science, the researchers have used a similar peptide to block the formation of IAPP clusters.

Feb 29, 2024

Light and sound may slow Alzheimer’s by making the brain remove toxins

Posted by in categories: biotech/medical, neuroscience

An experimental treatment for Alzheimer’s disease involving sounds and flickering lights has shown promise in mice and people. Now, research suggests the novel approach ramps up our brain’s waste disposal networks.

By Clare Wilson

Feb 29, 2024

Thing in itself

Posted by in categories: biological, mathematics, neuroscience

Alex Rosenberg is professor of Philosophy at Duke University and has made several important contributions to the philosophy of science, biology, and social science.

0:00 intro.
2:53 scientism.
5:09 naturalism and the manifest image.
7:25 pragmatism.
10:40 intentionality.
12:38 objections to eliminativism and truth.
14:35 consciousness.
16:50 biological functions, purposes, and the selected effects theory.
22:28 reductionism.
28:05 causality.
31:02 multiple realizability.
35:13 math.
39:45 morality.
44:51 humanism, art, and history.

Continue reading “Thing in itself” »

Feb 29, 2024

The Magic of Consciousness

Posted by in category: neuroscience

Wonderful presentation by Daniel Dennett on consciousness.

Feb 29, 2024

Alex Rosenberg | Intentionality, Evolution, and More

Posted by in categories: biological, evolution, neuroscience

Alex Rosenberg is the R. Taylor Cole Professor of Philosophy at Duke University. His research focuses on the philosophy of biology and science more generally, mind, and economics.

/ friction.
/ discord.
/ frictionphilo.

Continue reading “Alex Rosenberg | Intentionality, Evolution, and More” »

Feb 28, 2024

Roger Penrose’s Mind-Bending Theory of Reality

Posted by in categories: neuroscience, quantum physics

Nobel Laureate Sir Roger Penrose on his Orch OR theory of consciousness that could change what we know about time, the universe and reality, by incorporating the physics of consciousness. Explore mind blowing facts about our reality that show consciousness in quantum mechanics.

▶️ Read the article on Forbes.com https://rb.gy/s5uzf.
\

Feb 28, 2024

How sensory gamma rhythm stimulation clears amyloid in Alzheimer’s mice

Posted by in categories: biotech/medical, neuroscience

Stimulating a key brain rhythm with light and sound increases peptide release from interneurons, driving clearance of Alzheimer’s protein via the brain’s glymphatic system, new study suggests.

Feb 28, 2024

A First-of-Its-Kind Signal Was Detected in The Human Brain

Posted by in category: neuroscience

Scientists have identified a unique form of cell messaging occurring in the human brain, revealing just how much we still have to learn about its mysterious inner workings.

Excitingly, the discovery hints that our brains might be even more powerful units of computation than we realized.

Back in 2020, researchers from institutes in Germany and Greece reported a mechanism in the brain’s outer cortical cells that produces a novel ‘graded’ signal all on its own, one that could provide individual neurons with another way to carry out their logical functions.

Feb 28, 2024

Multiple Sclerosis Diagnostics/Genetic Scoring Could Expedite Sight-Saving Treatment

Posted by in categories: biotech/medical, genetics, neuroscience

The results of research led by scientists at the University of Exeter, and at King’s College London, suggests that young people could be spared from going blind by a new genetic risk tool that could also help predict patients who will progress to multiple sclerosis (MS) earlier, and get treatment started earlier. The study has shown for the first time that combining genetic risk for MS with demographic factors significantly improves MS risk prediction in people presenting with the eye disorder, which is called optic neuritis (ON).

Tasanee Braithwaite, MD, consultant ophthalmologist to the Medical Eye Unit at Guy’s and St Thomas NHS Foundation Trust, and adjunct senior lecturer at King’s College London said, “As a doctor caring for many patients with optic neuritis, I’m excited by the possibility of translating this pilot research into front line clinical care in the near future. Whilst more research is needed, our study provides a strong signal that we could better identify patients at high risk of MS, perhaps enabling these people to have earlier MS treatment in the future. Whereas, if we could better identify people whose optic neuritis is very unlikely to result from MS, we could treat these people urgently to reduce irreversible vision loss and blindness.”

Braithwaite is senior author of the team’s published paper in Nature Communications, titled “Applying a genetic risk score model to enhance prediction of future multiple sclerosis diagnosis at first presentation with optic neuritis,” in which they concluded, “This study indicates that a combined model might enhance individual MS risk stratification, paving the way for precision-based ON treatment and earlier MS disease-modifying therapy.”

Page 10 of 887First7891011121314Last